BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1091 related articles for article (PubMed ID: 30767754)

  • 1. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
    Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
    Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic malonate platinum(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidine derivatives: structural characterization and mechanism of the suppression of tumor cell growth.
    Łakomska I; Hoffmann K; Wojtczak A; Sitkowski J; Maj E; Wietrzyk J
    J Inorg Biochem; 2014 Dec; 141():188-197. PubMed ID: 25277461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platinum complexes with 5-methyl-5(4-pyridyl)hydantoin and its 3-methyl derivatives: synthesis and cytotoxic activity - quantitative structure-activity relationships.
    Bakalova A; Varbanov H; Buyukliev R; Momekov G; Ivanov D; Doytchinova I
    Arch Pharm (Weinheim); 2011 Apr; 344(4):209-16. PubMed ID: 21469169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents.
    Hoffmann K; Wiśniewska J; Wojtczak A; Sitkowski J; Denslow A; Wietrzyk J; Jakubowski M; Łakomska I
    J Inorg Biochem; 2017 Jul; 172():34-45. PubMed ID: 28477537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Stability, Cytotoxicity, and Mechanism of Action of Ru(II) and Pt(II) Complexes of a Bidentate N,O Donor Ligand.
    Maji M; Acharya S; Maji S; Purkait K; Gupta A; Mukherjee A
    Inorg Chem; 2020 Jul; 59(14):10262-10274. PubMed ID: 32585099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Platinum(IV) and Palladium(II) Transition Metal Complexes of s-Triazine Derivative: Synthesis, Spectral, and Anticancer Agents Studies.
    Al-Khodir FAI; Abumelha HMA; Al-Warhi T; Al-Issa SA
    Biomed Res Int; 2019; 2019():9835745. PubMed ID: 30906785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New platinum (II) and palladium (II) complexes of coumarin-thiazole Schiff base with a fluorescent chemosensor properties: Synthesis, spectroscopic characterization, X-ray structure determination, in vitro anticancer activity on various human carcinoma cell lines and computational studies.
    Şahin Ö; Özdemir ÜÖ; Seferoğlu N; Genc ZK; Kaya K; Aydıner B; Tekin S; Seferoğlu Z
    J Photochem Photobiol B; 2018 Jan; 178():428-439. PubMed ID: 29216566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NN'O] ligands: Synthesis, characterization, structural investigations and antiproliferative activity.
    Amiri Rudbari H; Saadati A; Aryaeifar M; Blacque O; Cuevas-Vicario JV; Cabral R; Raposo LR; Fernandes AR
    Bioorg Chem; 2022 Feb; 119():105556. PubMed ID: 34959175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
    Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
    J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel platinum(II) compounds with O,S bidentate ligands: synthesis, characterization, antiproliferative properties and biomolecular interactions.
    Mügge C; Liu R; Görls H; Gabbiani C; Michelucci E; Rüdiger N; Clement JH; Messori L; Weigand W
    Dalton Trans; 2014 Feb; 43(8):3072-86. PubMed ID: 24169734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with an L-alanyl-based ligand.
    Riccardi C; Capasso D; Rozza GM; Platella C; Montesarchio D; Di Gaetano S; Marzo T; Pratesi A; Messori L; Roviello GN; Musumeci D
    J Inorg Biochem; 2020 Feb; 203():110868. PubMed ID: 31837618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum(IV) complexes with some derivatives of 5-methyl-5-(4-pyridyl) hydantoin. Synthesis, study and comparative pharmacological investigation.
    Bakalova A; Buyukliev R; Ivanova Z; Momekov G; Ivanov D
    Drug Res (Stuttg); 2013 Aug; 63(8):420-3. PubMed ID: 23677699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.
    Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G
    Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
    Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
    J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of the Microtubule Network and Inhibition of VEGFR2 Phosphorylation by Cytotoxic
    Acharya S; Maji M; Chakraborty MP; Bhattacharya I; Das R; Gupta A; Mukherjee A
    Inorg Chem; 2021 Mar; 60(5):3418-3430. PubMed ID: 33554592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules.
    Savić A; Marzo T; Scaletti F; Massai L; Bartoli G; Hoogenboom R; Messori L; Van Deun R; Van Hecke K
    Biometals; 2019 Feb; 32(1):33-47. PubMed ID: 30367340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New platinum (II) complexes based on schiff bases: synthesis, specification, X-ray structure, ADMET, DFT, molecular docking, and anticancer activity against breast cancer.
    Eslami Moghadam M; Hasanzadeh Esfahani M; Behzad M; Zolghadri S; Ramezani N; Azadi Y
    J Biol Inorg Chem; 2023 Aug; 28(5):519-529. PubMed ID: 37452868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
    Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
    Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palladium(II) and platinum(II) bis(thiosemicarbazone) complexes of the 2,6-diacetylpyridine series with high cytotoxic activity in cisplatin resistant A2780cisR tumor cells and reduced toxicity.
    Matesanz AI; Leitao I; Souza P
    J Inorg Biochem; 2013 Aug; 125():26-31. PubMed ID: 23685347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.